iRhythm Holdings (IRTC) Free Cash Flow (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -298.11% |
| Dec 31, 2025 | -27.74% |
| Sep 30, 2025 | 150.56% |
| Jun 30, 2025 | 199.75% |
| Mar 31, 2025 | -164.76% |
| Dec 31, 2024 | 591.98% |
| Sep 30, 2024 | -111.78% |
| Jun 30, 2024 | 134.60% |
| Mar 31, 2024 | -9.76% |
| Dec 31, 2023 | -4,738.14% |
| Sep 30, 2023 | -67.57% |
| Jun 30, 2023 | 109.56% |
| Mar 31, 2023 | -211.44% |
| Dec 31, 2022 | 1,419.56% |
| Sep 30, 2022 | 83.90% |
| Jun 30, 2022 | 57.68% |
| Mar 31, 2022 | -121.34% |
| Dec 31, 2021 | -504.44% |
| Sep 30, 2021 | 167.57% |
| Jun 30, 2021 | 85.96% |
| Mar 31, 2021 | -944.39% |
| Dec 31, 2020 | 2.12% |
| Sep 30, 2020 | 143.30% |
| Jun 30, 2020 | 52.14% |
| Mar 31, 2020 | -54.53% |
| Dec 31, 2019 | -294.82% |
| Sep 30, 2019 | -65.58% |
| Jun 30, 2019 | 86.48% |
| Mar 31, 2019 | -221.65% |
| Dec 31, 2018 | 10.55% |
| Sep 30, 2018 | 12.34% |
| Jun 30, 2018 | 47.93% |
| Mar 31, 2018 | -210.06% |
| Dec 31, 2017 | -7.29% |
| Sep 30, 2017 | -121.83% |
| Jun 30, 2017 | 74.29% |
| Mar 31, 2017 | -302.82% |
| Dec 31, 2016 | 39.37% |
| Sep 30, 2016 | 27.65% |
| Jun 30, 2016 | 57.76% |
| Mar 31, 2016 | -73.25% |